Nicolas Grundmann is the Co-founder and CEO of Ember Health, which provides IV ketamine treatments for depression. As a board-certified emergency medicine physician, he launched Ember Health to create more effective, patient-centered treatment options. Nicolas is also a faculty member at the American Society of Ketamine Physicians, Psychotherapists and Practitioners, and is the Co-founder of Chenla Children’s Healthcare, which improves pediatric care in Cambodia.
Mental health treatment is evolving as clinicians search for options that outperform traditional approaches. From data-driven care to treating trauma, anxiety, and depression together, how can clinicians create evidence-based ketamine treatments?
According to emergency medicine physician Nicolas Grundmann, effective ketamine treatment starts with rigorous evidence, longitudinal data, and close care coordination. He emphasizes symptom-driven dosing, regular measurement using validated tools, and proactive follow-up to catch relapses early. Clinicians should also integrate outside therapists, help patients relearn emotional regulation after depression lifts, and avoid one-size-fits-all models.
In this episode of Living Medicine, Dr. Sandy Newes talks with Nicolas Grundmann, Co-founder and CEO of Ember Health, about evidence-based ketamine treatment for depression. Nicolas talks about using real-world data to guide care, treating depression with comorbid PTSD and anxiety, and whether to include therapy during ketamine sessions.
This episode is brought to you by the Living Medicine Institute.
LMI is a training, resource, and membership program educating providers about the legal and safe use of psychedelic-assisted psychotherapy.
To learn more or participate, visit https://livingmedicineinstitute.com.
Leave a Reply
You must be logged in to post a comment.